{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:45:08Z","timestamp":1791873908438,"version":"4.3.4"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"suppl_6","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI069397"],"award-info":[{"award-number":["AI069397"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI109025"],"award-info":[{"award-number":["AI109025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"DOI":"10.1093\/cid\/civ791","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T06:47:40Z","timestamp":1447397260000},"page":"S612-S617","source":"Crossref","is-referenced-by-count":363,"title":["Echinocandin Resistance in Candida"],"prefix":"10.1093","volume":"61","author":[{"given":"David S.","family":"Perlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"key\n\t\t\t\t20171014001842_CIV791C1","first-page":"165rv13","article-title":"Hidden killers: human fungal infections","volume":"4","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20171014001842_CIV791C2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C3","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C4","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","article-title":"Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C5","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/AAC.01711-09","article-title":"Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C6","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata","volume":"50","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C8","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1128\/AAC.03255-14","article-title":"Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata: results from the SENTRY Antimicrobial Surveillance Program (2006-2010) and the Centers for Disease Control and Prevention Population-Based Surveillance (2008-2010)","volume":"50","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs","volume":"6","year":"2011","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C12","article-title":"Mechanisms of antifungal drug resistance","volume":"5","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key\n\t\t\t\t20171014001842_CIV791C13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1128\/AAC.01162-08","article-title":"Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C14","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1128\/AAC.01811-10","article-title":"A new Fks hotspot for acquired echinocandin resistance in yeast, and its contribution to intrinsic resistance of Scedosporium species","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C15","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/AAC.00020-09","article-title":"Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C16","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/AAC.00443-09","article-title":"Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C17","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.06369-11","article-title":"Differential In vivo activity of anidulafungin, caspofungin and micafungin against C. glabrata with and without FKS resistance mutations","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/infdis\/jir023","article-title":"Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy","volume":"203","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C19","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1128\/AAC.01686-10","article-title":"Disseminated candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C20","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/AAC.01750-10","article-title":"Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C21","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1128\/AAC.00813-12","article-title":"Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(94)90633-5","article-title":"The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth","volume":"151","year":"1994","journal-title":"Gene"},{"key":"key\n\t\t\t\t20171014001842_CIV791C23","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1128\/AAC.01811-10","article-title":"New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JCM.01590-09","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp","volume":"48","year":"2010","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s15010-013-0455-6","article-title":"A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade","volume":"41","year":"2013","journal-title":"Infection"},{"key":"key\n\t\t\t\t20171014001842_CIV791C26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance","volume":"46","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C27","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/AAC.00262-08","article-title":"A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","article-title":"Resistance to echinocandin-class antifungal drugs","volume":"10","year":"2007","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20171014001842_CIV791C29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fgb.2009.09.003","article-title":"Fungal echinocandin resistance","volume":"47","year":"2010","journal-title":"Fungal Genet Biol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1365-2958.2007.05588.x","article-title":"The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans","volume":"63","year":"2007","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C31","doi-asserted-by":"crossref","first-page":"e1000040","DOI":"10.1371\/journal.ppat.1000040","article-title":"Stimulation of chitin synthesis rescues Candida albicans from echinocandins","volume":"4","year":"2008","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171014001842_CIV791C32","doi-asserted-by":"crossref","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","year":"2009","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171014001842_CIV791C33","doi-asserted-by":"crossref","first-page":"e1002718","DOI":"10.1371\/journal.ppat.1002718","article-title":"Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata","volume":"8","year":"2012","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171014001842_CIV791C34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.mib.2004.10.015","article-title":"Integrative studies put cell wall synthesis on the yeast functional map","volume":"7","year":"2004","journal-title":"Curr Opin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C35","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.fgb.2008.08.003","article-title":"Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity","volume":"45","year":"2008","journal-title":"Fungal Genet Biol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/AAC.00683-11","article-title":"Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C37","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/infdis\/jir351","article-title":"The fitness and virulence cost of fks1 mutations causing echinocandin-resistance in Candida albicans","volume":"204","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C38","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1371\/journal.ppat.0020035","article-title":"A drug-sensitive genetic network masks fungi from the immune system","volume":"2","year":"2006","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171014001842_CIV791C39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/589304","article-title":"Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure","volume":"198","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C40","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1128\/AAC.00563-06","article-title":"Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C41","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1128\/AAC.00044-11","article-title":"Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C42","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates","volume":"6","year":"2007","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20171014001842_CIV791C43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1128242","article-title":"Aneuploidy and isochromosome formation in drug-resistant Candida albicans","volume":"313","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20171014001842_CIV791C44","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/JCM.00381-07","article-title":"Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia","volume":"45","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/AAC.02020-13","article-title":"Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C46","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","article-title":"Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance","volume":"51","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C47","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JCM.00566-08","article-title":"Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints","volume":"46","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C48","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/AAC.01584-09","article-title":"In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","year":"2011","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20171014001842_CIV791C50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drup.2014.01.001","article-title":"Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp","volume":"16","year":"2013","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20171014001842_CIV791C51","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1111\/j.1469-0691.2011.03647.x","article-title":"EUCAST technical note on anidulafungin","volume":"17","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171014001842_CIV791C52","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2014.02.008","article-title":"The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods","volume":"79","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C54","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/JCM.02481-13","article-title":"Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria","volume":"52","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C55","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/JCM.00782-14","article-title":"Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria","volume":"52","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C56","first-page":"48492","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C57","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/AAC.02615-13","article-title":"Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C58","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C59","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s40265-014-0286-5","article-title":"Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management","volume":"74","year":"2014","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20171014001842_CIV791C60","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/AAC.00473-08","article-title":"Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C61","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s10096-014-2096-9","article-title":"Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?","volume":"33","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C62","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.02037-12","article-title":"Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C63","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1128\/AAC.01144-13","article-title":"Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C64","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1371\/journal.ppat.0040035","article-title":"Mucosal damage and neutropenia are required for Candida albicans dissemination","volume":"4","year":"2008","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171014001842_CIV791C65","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/SLA.0b013e31819ed914","article-title":"The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial","volume":"249","year":"2009","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t20171014001842_CIV791C66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhin.2009.02.009","article-title":"Candida colonisation as a source for candidaemia","volume":"72","year":"2009","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20171014001842_CIV791C67","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/JCM.32.4.975-980.1994","article-title":"Investigation of the sequence of colonization and candidemia in nonneutropenic patients","volume":"32","year":"1994","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/13.2.211","article-title":"Risk factors for candidemia in patients with acute lymphocytic leukemia","volume":"13","year":"1991","journal-title":"Rev Infect Dis"},{"key":"key\n\t\t\t\t20171014001842_CIV791C69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tim.2011.07.004","article-title":"Importance of Candida-bacterial polymicrobial biofilms in disease","volume":"19","year":"2011","journal-title":"Trends Microbiol"},{"key":"key\n\t\t\t\t20171014001842_CIV791C70","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/AAC.02378-12","article-title":"Role of matrix beta-1,3 glucan in antifungal resistance of non-albicans Candida biofilms","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C71","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1128\/IAI.00062-14","article-title":"Candida glabrata intra-abdominal candidiasis is characterized by persistence within the peritoneal cavity and abscesses","volume":"82","year":"2014","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171014001842_CIV791C72","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2165\/11209970-000000000-00000","article-title":"Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections","volume":"72","year":"2012","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20171014001842_CIV791C73","first-page":"27","article-title":"Micafungin: an evidence-based review of its place in therapy","volume":"9","year":"2014","journal-title":"Core Evid"},{"key":"key\n\t\t\t\t20171014001842_CIV791C74","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1592\/phco.27.12.1644","article-title":"Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients","volume":"27","year":"2007","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20171014001842_CIV791C75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.50.1.143-147.2006","article-title":"Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001842_CIV791C76","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinthera.2013.11.010","article-title":"Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis","volume":"36","year":"2014","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20171014001842_CIV791C77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/tid.12230","article-title":"Development of echinocandin-resistant Candida albicans candidemia following brief prophylactic exposure to micafungin therapy","volume":"16","year":"2014","journal-title":"Transpl Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_6\/S612\/20913876\/civ791.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T05:58:19Z","timestamp":1599803899000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/61\/suppl_6\/S612\/436893\/Echinocandin-Resistance-in-Candida"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":77,"journal-issue":{"issue":"suppl_6","published-online":{"date-parts":[[2015,11,5]]},"published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ791","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,12,1]]},"published":{"date-parts":[[2015,11,5]]}}}